Anebulo PharmaceuticalsANEB
那斯達克 · USD
3.19
-0.05
(-1.54%)
收盤 07/26 03:59 (UTC+8)
盤後
3.19
3.19
(0.00%)
07/26 03:59 (UTC+8)
Anebulo PharmaceuticalsANEB
3.19
-0.05
(-1.54%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 1,892 | 2,589 | 2,412 | 1,341 | 1,664 | 2,761 | 2,543 | 2,494 | 2,864 | 3,813 |
研發費用 | 638 | 1,221 | 1,315 | 468 | 748 | 1,063 | 1,270 | 1,417 | 1,089 | 1,870 |
推銷及管理費用 | 1,254 | 1,368 | 1,097 | 873 | 916 | 1,698 | 1,273 | 1,077 | 1,775 | 1,943 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -1,892 | -2,588 | -2,412 | -1,340 | -1,664 | -2,760 | -2,544 | -2,494 | -2,864 | -3,813 |
其他收入及費用 | 461 | 185 | 271 | 50 | 70 | 75 | 63 | -1 | 66 | -14 |
利息費用 | 245 | 60 | 60 | 60 | 60 | 32 | - | - | - | - |
稅前純益 | -1,676 | -2,463 | -2,201 | -1,350 | -1,654 | -2,717 | -2,481 | -2,496 | -2,798 | -3,827 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -1,676 | -2,463 | -2,201 | -1,350 | -1,654 | -2,717 | -2,481 | -2,496 | -2,798 | -3,827 |
基本每股稅後盈餘(元) | -0.04 | -0.09 | -0.08 | -0.05 | -0.06 | -0.11 | -0.10 | -0.10 | -0.11 | -0.15 |
稀釋每股稅後盈餘(元) | -0.03 | -0.09 | -0.08 | -0.05 | -0.07 | -0.10 | -0.10 | -0.10 | -0.11 | -0.15 |
基本平均股數(千股) | 41084.00 | 27415.00 | 25933.00 | 25934.00 | 25933.00 | 25789.00 | 25633.00 | 25633.00 | 25633.00 | 25633.00 |
稀釋平均股數(千股) | 41084.00 | 27415.00 | 25933.00 | 25934.00 | 25933.00 | 25789.00 | 25633.00 | 25633.00 | 25633.00 | 25633.00 |
還原基本每股稅後盈餘(元) | -0.04 | -0.09 | -0.08 | -0.05 | -0.06 | -0.11 | -0.10 | -0.10 | -0.11 | -0.15 |
還原稀釋每股稅後盈餘(元) | -0.03 | -0.09 | -0.08 | -0.05 | -0.07 | -0.10 | -0.10 | -0.10 | -0.11 | -0.15 |
還原基本平均股數(千股) | 41,084 | 27,415 | 25,933 | 25,934 | 25,933 | 25,789 | 25,633 | 25,633 | 25,633 | 25,633 |
還原稀釋平均股數(千股) | 41,084 | 27,415 | 25,933 | 25,934 | 25,933 | 25,789 | 25,633 | 25,633 | 25,633 | 25,633 |
EBITDA(千元) | -1,186 | -2,343 | -2,081 | -1,230 | -1,534 | -2,653 | -2,481 | -2,496 | -2,798 | -3,827 |